1. Home
  2. EOLS vs VTS Comparison

EOLS vs VTS Comparison

Compare EOLS & VTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EOLS
  • VTS
  • Stock Information
  • Founded
  • EOLS 2012
  • VTS 2014
  • Country
  • EOLS United States
  • VTS United States
  • Employees
  • EOLS N/A
  • VTS N/A
  • Industry
  • EOLS Biotechnology: Pharmaceutical Preparations
  • VTS Oil & Gas Production
  • Sector
  • EOLS Health Care
  • VTS Energy
  • Exchange
  • EOLS Nasdaq
  • VTS Nasdaq
  • Market Cap
  • EOLS 787.7M
  • VTS 798.6M
  • IPO Year
  • EOLS 2018
  • VTS N/A
  • Fundamental
  • Price
  • EOLS $11.35
  • VTS $25.68
  • Analyst Decision
  • EOLS Strong Buy
  • VTS Strong Buy
  • Analyst Count
  • EOLS 6
  • VTS 1
  • Target Price
  • EOLS $22.60
  • VTS $29.00
  • AVG Volume (30 Days)
  • EOLS 504.4K
  • VTS 141.6K
  • Earning Date
  • EOLS 11-06-2024
  • VTS 11-04-2024
  • Dividend Yield
  • EOLS N/A
  • VTS 8.09%
  • EPS Growth
  • EOLS N/A
  • VTS N/A
  • EPS
  • EOLS N/A
  • VTS 1.45
  • Revenue
  • EOLS $248,326,000.00
  • VTS $232,520,000.00
  • Revenue This Year
  • EOLS $33.43
  • VTS $19.53
  • Revenue Next Year
  • EOLS $32.44
  • VTS $0.87
  • P/E Ratio
  • EOLS N/A
  • VTS $17.95
  • Revenue Growth
  • EOLS 34.42
  • VTS 13.53
  • 52 Week Low
  • EOLS $9.65
  • VTS $19.63
  • 52 Week High
  • EOLS $17.82
  • VTS $28.41
  • Technical
  • Relative Strength Index (RSI)
  • EOLS 35.09
  • VTS 34.62
  • Support Level
  • EOLS $11.34
  • VTS $27.00
  • Resistance Level
  • EOLS $11.83
  • VTS $27.89
  • Average True Range (ATR)
  • EOLS 0.46
  • VTS 0.61
  • MACD
  • EOLS -0.00
  • VTS -0.28
  • Stochastic Oscillator
  • EOLS 14.41
  • VTS 0.00

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

Share on Social Networks: